Approval of the parent company financial statements for the year ended December 31, 2025; approval of the total amount of expenses and costs referred to in Article 39-4 of the French Tax Code
Approval of the consolidated financial statements for the year ended December 31, 2025
Granting of discharge to the directors
Appropriation of net income for the year ended December 31, 2025
Approval of the related-party agreement relating to the management of employee mobility within entities of the Mrieux Group and the Mrieux Foundation
Approval of the related-party sponsorship agreement between the Company and the bioMrieux Endowment Fund
Approval of the “We act for the Children” related-party sponsorship agreement between the Company and the bioMrieux Endowment Fund
Renewal of the term of office of Alexandre Mrieux as a director
Appointment of Franois Lacoste as a director
Appointment of Jean-Luc Belingard as a non-voting director (censeur)
Determination of the total annual compensation for directors
Approval of the compensation policy for corporate officers in accordance with Article L.22-10-8 of the French Commercial Code
Approval of the compensation policy for the Chairman of the Board of Directors in accordance with Article L.22-10-8 of the French Commercial Code
Approval of the compensation policy for the Chief Executive Officer in accordance with Article L.22-10-8 of the French Commercial Code
Approval of the compensation policy for the directors in accordance with Article L.22-10-8 of the French Commercial Code
Approval of the information concerning compensation for corporate officers referred to in Article L.22-10-9 I of the French Commercial Code
Approval of the fixed, variable and extraordinary elements making up the total compensation and benefits in kind, paid or due to Alexandre Mrieux for 2025
Approval of the fixed, variable and extraordinary elements making up the total compensation and benefits in kind, paid or due to Pierre Boulud for 2025
Approval of the amended share purchase plan rules for beneficiaries located in the State of California in the US, as adopted by the Chief Executive Officer
Authorization given to the Board of Directors to enable the Company to buy back its own shares
Authorization given to the Board of Directors to reduce the Company’s share capital by canceling treasury shares
Authorization to be given to the Board of Directors to carry out a capital increase reserved for employees participating in a company savings plan
Cancellation of shareholders’ pre-emptive subscription rights in favor of employees participating in a company savings plan
Authorization to be given to the Board of Directors to grant share subscription or purchase options, without pre-emptive subscription rights
Overall limit on authorizations to issue shares
Amendments to the Company's articles of association
Full powers granted to the bearer of an original copy of the minutes of this Meeting for the purpose of completing formalities